Compare Emtriva vs. Genvoya
Head-to-head comparisons of medication uses, side effects, ratings, and more.
Works with other medicines to treat HIV infection.
Emtriva (emtricitabine) is a first-line and commonly used drug that is taken in combination with other HIV medications to treat or prevent HIV.
Treats HIV infection.
Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir) is a convenient 4-in-1 medication. It's one of the first choices used to treat HIV infections and contains a newer medication that's safer for your kidneys and bones.
Upsides
- Emtriva (emtricitabine) is a first-line drug option used in combination with other HIV medications to treat HIV.
- Taken with or without food once a day.
- Emtriva (emtricitabine) is available in many combination tablets if you are looking to lower the number of pills you need to take daily for HIV treatment.
- Emtriva (emtricitabine) is available as a capsule as well as liquid form.
- First-choice treatment for HIV infections.
- One tablet contains four different HIV medications and is only taken once daily.
- Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir) has fewer side effects (headache, nausea, fatigue, diarrhea), and is safer on your kidneys and bones than Stribild.
Downsides
- Patients with kidney damage will need to be closely monitored by their doctors in order to provide an appropriate dose.
- Cannot be used by itself to treat or prevent HIV infection.
- Should be taken with food.
- Can increase cholesterol levels.
- Can interact with many other drugs.
Used for
- HIV infection
- HIV prevention
Dosage forms
- Pill
- Liquid
- Pill
Price
Lowest price
$538.96
Find instant savings near youLowest price
$3774.88
Find instant savings near youWant to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
18possible side effects
- Diarrhea23%
- Nausea18%
- Nasal stuffiness/runniness (Rhinitis)18%
- Rash17%
- Physical weakness and/or lack of energy16%
- Increased cough14%
- Headache13%
- Vomiting9%
- Abdominal pain8%
- Insomnia7%
- Depressive disorders6%
- "Pins and needles" feeling (paresthesia)5%
- Dyspepsia4%
- Muscle pain4%
- Dizziness4%
- Nerve weakness/numbness/pain4%
- Joint pain3%
- Abnormal dreams2%
Risks and risk factors
- Lactic acidosis | Enlarged, fatty liver
- Liver disease
- Women
- Obesity
- Worsening hepatitis B infection
- Hepatitis B Virus infection
- Immune reconstitution syndrome
- HIV
- Exposure to other infections
- Start of a new HIV medication
- Change in HIV therapy
- Similar medications
- HIV treatment
- Kidney Damage
- History of kidney damage
- Lactic acidosis | Enlarged, fatty liver
- Liver disease
- Women
- Obesity
- Worsening hepatitis B infection
- Hepatitis B Virus infection
- Kidney damage
- History of kidney damage
- Taking other medicines that can harm the kidneys
- Immune reconstitution syndrome
- HIV
- Exposure to other infections
- Start of a new HIV medication
- Change in HIV therapy
- Drug interactions
- Taking medicines that interact with Genvoya (elvitegravir / cobicistat / emtricitabine / tenofovir)